Pro Doc Irbesartan/HCTZ recall in Canada: impurity risk
In plain language
This recall involves Pro Doc Irbesartan/HCTZ tablets sold in Canada. It's being recalled because of an impurity above acceptable limits. Stop using the product and follow the return steps in the official notice.
What to do
- ["Stop using the product immediately.","Check the lot numbers provided in the official notice.","Return the product as instructed by your pharmacist or healthcare provider."]
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Pro Doc Irbesartan/HCTZ 150 mg/12.5 mg Tablet
Lot: JN4976, JU3231, JY1913
Pro Doc Irbesartan/HCTZ 300 mg/12.5 mg Tablet
Lot: JR7823, JR7824, JU7506
Pro Doc Irbesartan/HCTZ 300 mg/25 mg Tablet
Lot: JS0731
Why this matters
Impurity risk
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: JN4976, JU3231, JY1913, JR7823, JR7824, JU7506, JS0731
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Impurity risk
What should consumers do?
["Stop using the product immediately.","Check the lot numbers provided in the official notice.","Return the product as instructed by your pharmacist or healthcare provider."]
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Impurity risk
When was this product recalled?
This product was recalled on May 27, 2021.
Is the Pro Doc brand affected by this recall?
Yes, Pro Doc products are affected by this recall. This recall involves Pro Doc Irbesartan/HCTZ tablets sold in Canada. It's being recalled because of an impurity above acceptable limits. Stop using the product and follow the return steps in the official notice.